Skip to main content
CSL Limited (ASX: CSL)
Australia flag Australia · Delayed Price · Currency is AUD
276.57
-2.22 (-0.80%)
Dec 20, 2024, 4:10 PM AEST

CSL Limited Revenue

In the fiscal year ending June 30, 2024, CSL Limited had annual revenue of $14.80B USD with 11.19% growth. CSL Limited had revenue of $6.75B in the half year ending June 30, 2024, with 49.24% growth.

Revenue
$14.80B
Revenue Growth
+11.19%
P/S Ratio
6.02
Revenue / Employee
$452.63K
Employees
32,698
Market Cap
133.92B AUD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 202414.80B1.49B11.19%
Jun 30, 202313.31B2.75B26.02%
Jun 30, 202210.56B252.00M2.44%
Jun 30, 202110.31B1.16B12.67%
Jun 30, 20209.15B612.20M7.17%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ResMed Inc. 6.93B
Pro Medicus Limited 161.50M
Fisher & Paykel Healthcare Corporation Limited 1.74B
Cochlear Limited 2.24B
Sonic Healthcare Limited 8.97B
Telix Pharmaceuticals Limited 645.68M
Ramsay Health Care Limited 16.66B
Neuren Pharmaceuticals Limited 193.34M
Revenue Rankings

CSL Limited News

More News